NextCare Urgent Care Board of Directors:

FRED L. BROWN, MBA, FACHE
Fred L. Brown’s healthcare career spans 42 years. A noted advocate for America’s hospitals and health care organizations, he has served in many prominent leadership roles. He is currently Immediate Past Chairman and a member of the Board of Commissioners of the Joint Commission and Immediate Past Chairman of The National Kidney Foundation. Brown is known for his expertise in health care integration, governance, operations, public policy, diversity, spiritual care, community health and social responsibility and serves as a board member for publicly traded and private corporations as well. Brown is a Fellow of the American College of Healthcare Executives. 

Mr. Castleman is President and CEO of Syntiro Healthcare Services, Inc., a business process outsourcing, care management, and disease management company whose primary client is Duke University in Durham, North Carolina. Brought in to salvage the investment, Mr. Castleman divested the EMR technology business, disposed of losing operations and restored the business to profitability. Previously he was CEO of Physia Corporation, an Internet technology development company for a physician practice management software with offices in Houston and Washington DC. Mr. Castleman is also a director of FemPartners, Inc., a physician practice management company in Houston. He is chairman of Electro-Optical Sciences, Inc., (NASDAQ: MELA) a development stage diagnostic medical device company in Irvington, NY. Mr. Castleman’s career prior to this reflects 24 years of expertise within strategic healthcare leadership roles, both nationally and globally. Mr. Castleman holds a bachelors degree in economics from Yale University and attended New York University Graduate School of Business Administration. He has published articles on management issues in business and technical periodicals, including the Harvard Business Review, and has presented numerous papers and presentations to industry groups in agribusiness, banking, energy and healthcare. Mr. Castleman served on the University of Michigan Health System Advisory Group. He has had extensive dealings with private equity firms and securities analysts, investment banks, and venture capital funds.                                                                                                                        

 

After a distinguished career in the public and private sectors, David Lowenberg is currently consulting with C-suite executives in health care and private equity firms and is a senior advisor to several health care companies. He recently retired as president and chief executive officer of Curascript, Inc., the specialty pharmacy business of Express Scripts, Inc., (ESI). ESI is one of the largest, most successful pharmacy benefit managers with revenues of $18 billion serving 150 million members in the U.S. and Canada. Curascript is a $3 billion enterprise – created through the acquisition of two specialty pharmacy companies in 2004-05. Prior to his appointment in the chief executive role, he was chief operating officer at ESI, with responsibility for leading the development and operations including mail-order pharmacy sites, information systems automation and supply chain contracting with pharmaceutical manufacturers and retail stores.  He also served as the lead business executive responsible for assessing and managing acquisitions to better integrate, develop and realize important synergies. Prior to his work in the commercial sector, he worked as an executive with both local and state government of Arizona.  He negotiated health care payment arrangements on behalf of the State with the Federal Government.  He was deputy director of the Arizona Medicaid Program for several years before serving as executive director of the Arizona Welfare Department. He has a master’s degree in public management from the John F. Kennedy School of Government at Harvard University.  He also has a graduate degree in criminal justice administration from San Diego State University.